Mecanismo de acción de moléculas con actividad biológica ; Mechanisms of action of biolocally active compounds
Moabac
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (3)
2020
2017
-
Structural rationale for the cross-resistance of tumor cells bearing the A399V variant of elongation factor eEF1A1 to the structurally unrelated didemnin B, ternatin, nannocystin A and ansatrienin B
Journal of Computer-Aided Molecular Design, Vol. 31, Núm. 10, pp. 915-928
2016
-
Stepwise Simulation of 3,5-Dihydro-5-methylidene-4H-imidazol-4-one (MIO) Biogenesis in Histidine Ammonia-lyase
Biochemistry, Vol. 55, Núm. 41, pp. 5854-5864